Editorial Review

Kidney International (1984) 26, 253–262; doi:10.1038/ki.1984.167

Peritoneal dialysis and loss of proteins: A review

John T Dulaney1 and Fred E Hatch Jr1

1Memphis, Tennessee

Correspondence: Dr J T Dulaney, Division of Nephrology, College of Medicine, University of Tennessee Center for the Health Sciences, 951 Court Avenue, 649D, Memphis, Tennessee 38163, USA

Received 22 August 1983; Revised 14 December 1983.

Top

References

  1. Babb AL, Johansen PJ, Strand MJ, Tenckhoff H, Scribner BH: Bi–directional permeability of the human peritoneum to middle molecules, in Dialysis, Transplantation, Nephrology (Proc Tenth Congr Eur Dial Trans Assoc, Vienna, Austria, 1973), edited by Moorhead JF, London, Pitman Medical, 1973, p 247
  2. Migone L, Dall'Aglio P, Buzio C: Middle molecules in uremic serum, urine and dialysis fluid. Clin Nephrol 3:82–93, 1975
  3. Bergström J, Fürst P, Zimmerman L: Uremic middle molecules exist and are biologically active. Clin Nephrol 11:229–238, 1979 | PubMed | ISI | ChemPort |
  4. Randerson DH, Chapman GV, Farrell PC: Amino acid and dietary status in CAPD patients, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 187
  5. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21:9–36 1982
  6. Berlyne GM, Jones JH, Hewitt V, Nilwarangkur S: Protein loss in peritoneal dialysis. Lancet 1:738–741, 1964
  7. Gordon S, Rubini ME: Protein losses during peritoneal dialysis. Am J Med Sci 253:283–292, 1967
  8. McKelvey EM, Yeoh HH, Schuster GA, Sharma B, Levin NW: Immunoglobulin and dextran losses during peritoneal dialysis. Arch Intern Med 134:266–269, 1974
  9. Giacchino F, Quarello F, Pellerey M, Piccoli G: Continuous ambulatory peritoneal dialysis improves immunodeficiency in uremic patients. Nephron 35:209–210, 1983
  10. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19:593–602, 1981 | PubMed | ISI | ChemPort |
  11. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 88:449–456, 1978 | PubMed | ISI | ChemPort |
  12. Giangrande A, Limido A, Cantu P, Allaria P: SDS-Polyacrylamide electrophoresis of protein loss during continuous ambulatory peritoneal dialysis. Ric Clin Lab 10:117–120, 1980
  13. Katirtzoglou A, Oreopoulos DG, Husdan H, Leung M, Ogilvie R, Dombros N: Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 26:230–233, 1980
  14. Diaz-Buxo JA, Walker PJ, Farmer CD, Chandler JT, Holt KL, Cox P: Continuous cyclic peritoneal dialysis. Trans Am Soc Artif Intern Organs 27:51–53, 1981
  15. Rubin J, Nolph KD, Arfania D, Prowant B, Fruto L, Brown P, Moore H: Protein losses in continuous ambulatory peritoneal dialysis. Nephron 28:218–221, 1981
  16. Twardowski Z, Ksiazek A, Majdan M, Janicka L, Bochenska-Nowacka E, Sokolowska G, Gutka A, Zbikowska A: Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day. Clin Nephrol 15:119–130, 1981
  17. Baran H, Lebek R, Spett K. Twardowski Z: Kinetics of protein loss during peritoneal dialysis. Pol Med J 11:277–280, 1972
  18. Nolph KD, Twardowski ZJ, Popovich RP, Rubin J: Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 93:246–256, 1979
  19. Miller FN, Nolph KD, Harris PD, Rubin J, Wiegman DL, Joshua IG, Twardowski ZJ, Ghods AJ: Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 15:630–639, 1979
  20. Rubin J, Nolph K, Arfania D, Brown P, Prowant B: Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 16:619–623, 1979
  21. Miller FN, Nolph KD, Sorkin MI, Gloor HJ: The influence of solution composition on protein loss during peritoneal dialysis. Kidney Int 23:35–39, 1983
  22. Kelton JG, Ulan R, Stiller C, Holmes E: Comparison of chemical composition of peritoneal fluid and serum. A method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo. Ann Intern Med 89:67–70, 1978
  23. Alavi N, Lianos E, Mookerjee B, Beam T: A study of inflammatory parameters on early asymptomatic peritonitis in chronic peritoneal dialysis (abstract). Kidney Int 19:141, 1981
  24. Rubin J, Nolph KD, Arfania D, Joshua IG, Miller FN, Wiegman DL, Harris PD: Clinical studies with a nonvasoactive peritoneal dialysis solution. J Lab Clin Med 93:910–915, 1979
  25. Brown EA, Kliger AS, Goffinet J, Finkelstein FO: Effect of hypertonic dialysate and vasodilators on peritoneal dialysis clearances in the rat. Kidney Int 13:271–277, 1978 | PubMed |
  26. Miller FN, Joshua IG, Harris PD, Wiegman DL, Jauchem JR: Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol 17:51–58, 1979 | PubMed |
  27. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB: Hyperosmolality, acetate, and lactate: Dilatory factors during peritoneal dialysis. Kidney Int 20:397–402, 1981 | PubMed |
  28. Finkelstein FO, Kliger AS, Bastl C, Yap P: Sequential clearance and dialysance measurements in chronic peritoneal dialysis patients. Nephron 18:342–347, 1977
  29. Blumenkrantz MJ, Moran JK, Coburn JW: Peritoneal clearances during prolonged maintenance peritoneal dialysis in diabetic and non-diabetic patients (abstract). Kidney Int 14:671, 1978
  30. Rubin J, Arfania D, Nolph KD, Prowant B, Fruto L, Brown P, Moore H: Peritoneal clearances after 6–12 months on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 25:104–109, 1979
  31. Farrell PC, Randerson DH: Membrane permeability changes in long-term CAPD. Trans Am Soc Artif Intern Organs 26:197–200, 1980
  32. Diaz-Buxo JA, Chandler JT, Farmer CD, Walker PJ, Holt KL, Orr SL: Long–term observations of peritoneal clearances in patients undergoing peritoneal dialysis (abstract). Kidney Int 21:166, 1982
  33. Nolph KD: Peritoneal clearances. J Lab Clin Med 94:519–525, 1979
  34. Kushner I, Somerville JA: Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum 14:560–570, 1971
  35. Nolph KD, Stoltz ML, Maher JF: Altered peritoneal permeability in patients with systemic vasculitis. Ann Intern Med 75:753–755, 1971
  36. Brown ST, Ahearn DJ, Nolph KD: Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol. Ann Intern Med 78:891–894, 1973
  37. Maathuis JB, Van Look PFA, Michie EA: Changes in volume, total protein and ovarian steroid concentrations of peritoneal fluid throughout the human menstrual cycle. J Endocrinol 76:123–133, 1978
  38. Salat-Baroux J, Scemama-Kestenberg H, Couturier JY, Firmin C, Agnes E, Levy G, Vuillard E: Etudes hormonales post-ovulatoires dans les compartiments plasmatique, peritonealet folliculaire. J Gynecol Obstet Biol Reprod (Paris) 11:447–156, 1982
  39. Maher JF, Hirszel P, Lasrich M: Effects of gastrointestinal hormones on transport by peritoneal dialysis. Kidney Int 16:130–136, 1979
  40. Rasio EA: Metabolic control of permeability in isolated mesentery. Am J Physiol 226:962–968, 1974 | PubMed | ISI | ChemPort |
  41. Carter RD, Joyner WL, Renkin EM: Effects of histamine and some other substances on molecular selectivity of the capillary wall to plasma proteins and dextran. Microvasc Res 7:31–48, 1974
  42. Hirszel P, Lasrich M, Maher JF: Arachidonic acid increases peritoneal clearances. Trans Am Soc Artif Intern Organs 27:61–63, 1981
  43. Williams TJ: Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol 65:517–524, 1979 | PubMed | ChemPort |
  44. Jose PJ, Forrest MJ, Williams TJ: Human C5a des Arg increases vascular permeability. J Immunol 127:2376–2380, 1981 | PubMed | ISI | ChemPort |
  45. Williams TJ: Vascular permeability changes induced by complement-derived peptides. Agents Actions 13:451–455, 1983 | PubMed | ISI | ChemPort |
  46. Greenbaum LM, Semente G, Prakash A, Roffman S: Leukokinins: their pharmacological properties and role in the pathology of fluid (ascites) accumulation. Agents Actions 8:80–84, 1978
  47. Greenbaum LM, Semente G, Grebow P, Roffman S: The isolation of leukokinin-H and leukokininogen from human ascites fluid; their properties and role, in Kinins-II: Systemic Proteases and Cellular Function (Advances in Experimental Medicine and Biology, Vol. 120B), edited by Fujii S, Moriya H, Suzuki T, New York, Plenum Press, 1979, pp 205–214
  48. Maher JF: Interactions of drugs and peritoneal dialysis. Proc Clin Dial Transp Forum 8:168–170, 1978
  49. Palade GE, Simionescu M, Simionescu N: Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand [Suppl] 463:11–32, 1979 | ChemPort |
  50. Wagner RC, Casley-Smith JR: Endothelial vesicles. Microvasc Res 21:267–298, 1981
  51. Simionescu M, Simionescu N, Palade GE: Biochemically differentiated microdomains of the cell surface of capillary endothelium. Ann NY Acad Sci 401:9–24, 1982
  52. Renkin EM, Curry FE: Endothelial permeability: Pathways and modulations. Ann NY Acad Sci 401:248–259, 1982
  53. Bundgaard M: Vesicular transport in capillary endothelium: Does it occur? Fed Proc 42:2425–2430, 1983 | PubMed | ISI | ChemPort |
  54. Schneeberger EE: Proteins and vesicular transport in capillary endothelium. Fed Proc 42:2419–2424, 1983
  55. Casley-Smith JR: Calculations relating to the passage of fluid and protein out of arterial-limb fenestrae, through basement membranes and connective tissue channels, and into venous-limb fenestrae and lymphatics. Microvasc Res 12:13–34, 1976
  56. Böhn GM: Vascular events in inflammation. Agents Actions [Suppl] 3:31–50, 1977
  57. Johansson BR: Permeability of muscle capillaries to interstitially microinjected ferritin. Microvasc Res 16:362–368, 1978
  58. Aplin JD, Hughes RC: Complex carbohydrates of the extracellular matrix: Structures, interactions and biological roles. Biochim Biophys Acta 694:375–418, 1982
  59. Martinez-Hernandez A, Amenta PS: The basement membrane in pathology. Lab Invest 48:656–677, 1983 | PubMed | ChemPort |
  60. Laurie GW, LeBlond CP: What is known of the production of basement membrane components. J Histoehem Cytochem 31:159–163, 1983
  61. Baradi AF, Hope J: Observations on ultrastructure of rabbit mesothelium. Exp Cell Res 34:33–44, 1964
  62. Nagel W, Kuschinsky W: Study of the permeability of the isolated dog mesentery. Eur J Clin Invest 1:149–154, 1970 | PubMed | ISI | ChemPort |
  63. Cotran RS, Karnovsky MJ: Ultrastructural studies on the permeability of the mesothelium to horseradish peroxidase. J Cell Biol 37:123–137, 1968 | Article | PubMed | ISI | ChemPort |
  64. Courtice FC, Roberts DCK: Peritoneal fluid in the rabbit: Permeability of the mesothelium to proteins, lipoproteins and acid hydrolases. Lymphology 8:1–10, 1975
  65. Simionescu M, Simionescu N: Organization of cell junctions in the peritoneal mesothelium. J Cell Biol 74:98–110, 1977 | Article | PubMed | ISI | ChemPort |
  66. Leak LV, Rahil K: Permeability of the diaphragmatic mesothelium: The ultrastructural basis of "stomata". Am J Anat 151:557–594, 1978
  67. Tsilibary EC, Wissig SL: Lymphatic absorption from the peritoneal cavity: Regulation of patency of mesothelial stomata. Microvasc Res 25:22–39, 1983
  68. Nolph KD, Miller F, Rubin J, Popovich R: New directions in peritoneal dialysis concepts and applications. Kidney Int 18(Suppl): S111–S116, 1980
  69. Maher FJ: Peritoneal transport rates: Mechanisms, limitations, and methods for augmentation. Kidney Int 18 (Suppl):S117–S120, 1980
  70. Nolph KD, Miller FN, Pyle WK, Popovich RP, Sorkin MI: An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis. Kidney Int 20:543–548, 1981
  71. Sorkin MI, Nolph KD: Dynamics of peritoneal transfer, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 12
  72. Dobbie JW, Zaki M, Wilson L: Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 26:213–223, 1981
  73. Verger C, Brunschvicg O, Le Charpentier Y, Lavergne A, Vantelon J: Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 18:199–205, 1981 | PubMed | ISI | ChemPort |
  74. Schliep G, Felgenhauer K: Serum-CSF protein gradients, the blood-CSF barrier and the local immune response. Neurology 218:77–96, 1978
  75. Sliwinski AJ, Zvaifler NJ: In vivo synthesis of IgG by rheumatoid synovium. J Lab Clin Med 76:304–310, 1970
  76. Kuusela P, Vaheri A, Palo J, Ruoslahti E: Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med 92:595–601, 1978
  77. Carsons S, Mosesson MW, Diamond HS: Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum 24:1261–1267, 1981
  78. Vartio T, Vaheri A, Von Essen R, Isomäki H, Stenman S: Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest 11:207–212, 1981
  79. Ganguly R, Milutinovich J, Lazzell V, Waldman RH: Studies of human peritoneal cells: A normal saline lavage technique for the isolation and characterization of cells from peritoneal dialysis patients. J Reticuloendothel Soc 27:303–310, 1980
  80. Nolph KD, Sorkin MI, Prowant BF, Kennedy JM, Everett ED: Asymptomatic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Dialysis Transplant 11:309–313, 1982
  81. Leak LV: Interaction of mesothelium to intraperitoneal stimulation. I. Aggregation of peritoneal cells. Lab Invest 48:479–491, 1983 | PubMed |
  82. Baggiolini M, Bretz U, Dewald B, Feigenson ME: The polymorphonuclear leukocyte. Agents Actions 8:3–10, 1978
  83. Allison AC, Ferluga J, Prydz H, Schorlemmer HU: The role of macrophage activation in chronic inflammation. Agents Actions 8:27–35, 1978
  84. Brade V, Kreuzpaintner G: Functional active complement components secreted by guinea pig peritoneal macrophages. Immunobiology 161:315–321, 1982
  85. Aalto M, Kulonen E, Penttinen R, Renvall S: Collagen synthesis in cultured mesothelial cells. Response to silica. Acta Chir Scand 147:1–6, 1981 | PubMed | ISI | ChemPort |
  86. Kurkinen M, Vaheri A, Roberts PJ, Stenman S: Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest 43:47–51, 1980 | PubMed | ISI | ChemPort |
  87. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140:1201–1203, 1980 | Article | PubMed | ISI | ChemPort |
  88. Vas SI, Duwe A, Weatherhead J: Natural defense mechanisms of the peritoneum: The effect of peritoneal dialysis fluid on polymorphonuclear cells, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 41
  89. Breckenridge WC, Roncari DAK, Khanna R, Oreopoulos DG: The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis 45:249–258, 1982 | Article | PubMed | ChemPort |
  90. Sorkin MI, Luger AM, Prowant B, Kennedy J, Moore H, Nolph KD: Histological and functional characteristics of the peritoneal membrane of a diabetic patient after 34 months of CAPD. Periton Dial Bull 2:24–27, 1982
  91. Kowalewski J, Tomaszewski J, Hanzlik J, Zawislak H, Zbikowska A: The elimination of free, peptide-bound and protein-bound hydroxyproline into dialysate during peritoneal dialysis in patients with renal failure. Clin Chim Acta 34:123–126, 1971
  92. Maher JF, Hirszel P, Hohnadel DC, Abraham J, Lasrich M: Fatty acid removal during peritoneal dialysis: Mechanisms, rates and significance. Am Soc Artif Intern Organs J 1:8–14, 1978
  93. Mariani G, Bianchi R, Pilo A, Palla R, Toni MG, Cazzuola F: Double isotope measurement of peritoneal clearance of iodide and albumin loss during peritoneal dialysis in man. Eur J Clin Invest 5:109–114, 1975
  94. Bianchi R, Mariani G, Pilo A, Carmassi F: Mechanisms of albumin loss during peritoneal dialysis in man. Eur J Clin Invest 5:409–413, 1975
  95. Delmez JA, Slatopolsky E, Martin KJ, Gearing BN, Harter HR: Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 21:862–867, 1982 | PubMed | ISI | ChemPort |
  96. Kuska J: Activity of certain enzymes in blood plasma and dialyzing fluid in patients with renal failure treated with peritoneal dialysis. Pol Med J 9:46–50, 1970
  97. Henderson JM, Stein SF, Kutner M, Wiles M-B, Ansley JD, Rudman D: Analysis of twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Ann Surg 192:738–742, 1980
  98. Felgenhauer K: Protein size and cerebrospinal fluid composition. Klin Wochenschr 52:1158–1164, 1974
  99. Levick JR: Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 24:1550–1560, 1981
  100. Felgenhauer K: Protein filtration and secretion at human body fluid barriers. Pflugers Arch 384:9–17, 1980
  101. Rothschild MA, Oratz M, Schreiber SS: Albumin synthesis. New Engl J Med 286:748–757, 1972
  102. Stott DI, Williamson AR: Immunoglobulins and histocompatibility antigens. Their structure, function and metabolism, in Comprehensive Biochemistry, vol 19B Part II, Protein Metabolism, edited by Neuberger A, Van Deenen LLM, Amsterdam, Elsevier, 1982, p 189
  103. Kernoff LM, Baker G: Direct measurement of transferrin synthesis rates in man using the [14C]carbonate method. Anal Biochem 106:529–534, 1980
  104. Katz JH: Iron and protein kinetics studied by means of doubly labeled human crystalline transferrin. J Clin Invest 40:2143–2152, 1961 | PubMed | ISI | ChemPort |
  105. Oreopoulos DG: Introductory remarks: Selection criteria and clinical results of continuous ambulatory peritoneal dialysis, in Continuous Ambulatory Peritoneal Dialysis (Proc Int Symp, Paris, Nov 2–3, 1979), edited by LeGrain M, Amsterdam, Excerpta Medica, 1980, p 101
  106. Lindholm B, Alvestrand A, Fürst P, Tranaeus A, Bergström J: Efficacy and clinical experience of CAPD—Stockholm, Sweden, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 147
  107. Durkin MG, Essig LJ, Nolph KD: Peritoneal dialysance of gastrin (abstract). Clin Res 20:40, 1972
  108. Chan MK, Baillod RA, Varghese Z, Sweeny P, Moorhead JF: Immunoglobulins and complement components (C3, C4) in CAPD and hemodialysis patients. Dialysis Transplant 12:777–778, 1983
  109. Nolph KD, Sorkin M, Rubin J, Arfania D, Prowant B, Fruto L, Kennedy D: Continuous ambulatory peritoneal dialysis: Three-year experience at one center. Ann Intern Med 92:609–613, 1980 | PubMed | ISI | ChemPort |
  110. Stone WJ, Latos DL, Lankford PG, Baker AS: Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure and Factor X deficiency. South Med J 71:764–767, 1978
  111. Yium J, Martinez-Maldonado M, Eknoyan G, Suki WN: Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J 64:1403–1405, 1971
  112. Russell JA, Fitzharris BM, Corringham R, Darcy DA, Powles RL: Plasma exchange v peritoneal dialysis for removing Bence-Jones protein. Br Med J 2:1397, 1978
  113. Marshall JS, Williams S: Serum inhibitors of desialylated glycoprotein binding to hepatocyte membranes. Biochim Biophys Acta 543:41–52, 1978
  114. Fasman GD (editor): Handbook of Biochemistry and Molecular Biology: Proteins-Volume II (3rd ed). Cleveland, CRC Press, 1976, pp 242–256, 258–259
  115. Koninckx PR, Heyns W, Verhoeven G, Van Baelen H, Lissens WD, De Moor P, Brosens IA: Biochemical characterization of peritoneal fluid in women during the menstrual cycle. J Clin Endocrinol Metab 51:1239–1244, 1980
  116. Pattinson HA, Koninckx PR, Brosens IA, Vermylen J: Clotting and fibrinolytic activities in peritoneal fluid. Br J Obstet Gynaecol 88:160–166, 1981
  117. Koninckx PR, Renaer M, Brosens IA: Origin of peritoneal fluid in women: An ovarian exudation product. Br J Obstet Gynaecol 87:177–183, 1980
  118. Lutz W: Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity. Acta Med Pol 20:131–141, 1979
  119. Furman KI, Gomperts ED, Hockley J: Activity of intraperitoneal heparin during peritoneal dialysis. Clin Nephrol 9:15–18, 1978
  120. Nevo Z: Growth factors. Am J Dis Child 133:419–428, 1979
  121. Arimura A, Schally AV: Hypothalamic releasing and inhibiting hormones and factors, in Hormones in Blood (3rd ed), edited by Gray CH, James VHT, New York, Academic Press, 1979, p 1
  122. Blumenkrantz MJ, Lewin AJ, Roberts M, Miller JH, Maxwell MH: Sorbent peritoneal dialysis: An approach to a wearable kidney, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 245
  123. Oreopoulos DG, Crassweller P, Katirtzoglou A, Ogilvie R, Zellerman G, Rodella H, Vas SI: Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis, in Continuous Ambulatory Peritoneal Dialysis (Proc Int Symp, Paris, Nov 2–3, 1979), edited by LeGrain M, Amsterdam, Excerpta Medica, 1980, p 335
  124. Nolph KD, Sorkin MI, Gloor HJ: Considerations for dialysis solution modifications, in Peritoneal Dialysis, edited by Atkins RC, Thomson NM, Farrell PC, New York, Churchill Livingstone, 1981, p 236
  125. Bernard DB: Metabolic abnormalities in nephrotic syndrome: Pathophysiology and complications, in Nephrotic Syndrome (Contemporary Issues in Nephrology, Vol. 9), edited by Brenner BM, Stein JH, New York, Churchill Livingstone, 1982, p 85

Extra navigation

.
ADVERTISEMENT